Multivariate associations between body mass index (BMI) at the start of dialysis and access to kidney transplantation.

<p>*Adjusted for gender, age, congestive heart failure, diabetes, chronic respiratory disease, coronary heart disease, cardiac dysrhythmia, peripheral vascular disease, active cancer disease and stroke.</p

Flow chart for sample selection (RRT: Renal replacement therapy).

<p>Relative to the excluded patients, the included patients did not differ significantly in terms of gender and the prevalence of congestive heart failure but were older (+1 year, p<0.001), had a slight lower eGFR at initiation (-0.2ml/min, p = 0.03), were less likely to have diabetes (-2%, p<0.002) and had different patterns of initially treated conditions or primary renal disease (Table A in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0176616#pone.0176616.s001" target="_blank">S1 File</a>).</p

Multivariate associations (hazard ratios and 95% confidence intervals derived from joint models) for access to transplantation for BMI in different multivariate joint models stratified on three levels of initial BMI with competing risk of death.

<p>Multivariate associations (hazard ratios and 95% confidence intervals derived from joint models) for access to transplantation for BMI in different multivariate joint models stratified on three levels of initial BMI with competing risk of death.</p

Patient characteristics according to the BMI level at start of dialysis.

<p>Patient characteristics according to the BMI level at start of dialysis.</p

Multivariate associations (hazard ratios and 95% confidence intervals derived from joint models) for overall mortality for BMI in different multivariate joint models stratified on three levels of initial BMI.

<p>Multivariate associations (hazard ratios and 95% confidence intervals derived from joint models) for overall mortality for BMI in different multivariate joint models stratified on three levels of initial BMI.</p

Odds ratios and 95% CIs for the relation of between common mental disorder among non-obese subjects at baseline (1984) and the development of global or abdominal obesity at re-survey (1991).

<p>GHQ: 30 items General health questionnaire. BMI: body mass index. WC: waist circumference.</p><p>Multinomial logistic regression models were used with subjects having a body mass index between 18.5 and 24.9 kg/m² (both gender) or a waist circumference < 94 cm (men) /80 cm (women) being the reference.</p><p>Model 1: Adjusted for baseline age</p><p>Model 2: adjusted for baseline age, marital status, socio-economic status, alcohol consumption, tobacco smoking and physical activity.</p><p>Odds ratios and 95% CIs for the relation of between common mental disorder among non-obese subjects at baseline (1984) and the development of global or abdominal obesity at re-survey (1991).</p

Odds ratios and 95% CIs for the relation between general or abdominal obesity among subjects free of common mental disorders at baseline (1984) and the development of common mental disorders at the re-survey study (1991).

<p>GHQ: 30 items General health questionnaire. BMI: body mass index. WC: waist circumference.</p><p>Model 1: Adjusted for baseline age</p><p>Model 2: adjusted for baseline age, marital status, socio-economic status, alcohol consumption, tobacco smoking and physical activity.</p><p>Odds ratios and 95% CIs for the relation between general or abdominal obesity among subjects free of common mental disorders at baseline (1984) and the development of common mental disorders at the re-survey study (1991).</p

Participants selection flow in the HALS.

<p>*These subjects with missing data for any of the following covariates: age, general health questionnaire, marital status, occupational social class, alcohol consumption, smoking status, height, weight and waist circumference.</p

Baseline plasma lipid profile of SU.FOL.OM3 participants without and with major events, cardiac and cerebrovascular events at the end of the follow-up.

<p>All values are expressed as percentage of total plasma fatty acids, except for total plasma fatty acids.</p><p>P values are for the comparison of ^*major, †cardiac and ‡cerebrovascular events with participants without events at the end of the study, after adjusting for total energy intake.</p

Multivariate hazard ratios (95% confidence intervals) showing the associations between baseline plasma lipid profile and incident cardiac events in the SU.FOL.OM3 study.

<p>Model 1: adjusted for age, BMI, initial event, gender.</p><p>Model 2: adjusted for covariates in Model 1 + treatment allocation group (both placebos, B vitamin and placebo of omega 3, omega 3 and placebo of B vitamins, omega 3 and B vitamins),, tobacco smoking, alcohol consumption, systolic blood pressure, diabetes status, plasma cholesterol (HDL and LDL), triglycerides, total fatty acid intake, n-3 supplementation and homocysteinemia.</p